Michael Samarinas

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

External validation of the prostatic inflammation nomogram to predict prostatic inflammation in men with lower urinary tract symptoms.

External validation of the prostatic inflammation nomogram to predict prostatic inflammation in men with lower urinary tract symptoms.

Journal: Minerva urology and nephrology

Published: May 14, 2026

Optimizing the Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: An ESSIC Proposal.

Optimizing the Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: An ESSIC Proposal.

Journal: European urology open science

Published: April 19, 2026

Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?

Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?

Journal: Reviews in cardiovascular medicine

Published: April 14, 2026

The Role of the Aging Bladder in Lower Urinary Tract Symptoms: Pathophysiology and Therapeutic Implications in Patients with Benign Prostatic Hyperplasia.

The Role of the Aging Bladder in Lower Urinary Tract Symptoms: Pathophysiology and Therapeutic Implications in Patients with Benign Prostatic Hyperplasia.

Journal: Medicina (Kaunas, Lithuania)

Published: February 27, 2026

Erectile Function Decline in Men with Chronic Kidney Disease: A Three-Year Case-Control Study Comparing Haemodialysis, Non-Dialysis CKD and Community Controls.

Erectile Function Decline in Men with Chronic Kidney Disease: A Three-Year Case-Control Study Comparing Haemodialysis, Non-Dialysis CKD and Community Controls.

Journal: Journal of clinical medicine

Published: January 21, 2026

Effect of Bladder Injections of Botulinum Neurotoxin A on Biomarkers Associated with Inflammation and Urinary Infections in Patients with Neurogenic Detrusor Overactivity-Associated Incontinence: A Pilot, Prospective, Human Study.

Effect of Bladder Injections of Botulinum Neurotoxin A on Biomarkers Associated with Inflammation and Urinary Infections in Patients with Neurogenic Detrusor Overactivity-Associated Incontinence: A Pilot, Prospective, Human Study.

Journal: International journal of molecular sciences

Published: December 24, 2025

Phenotyping Overactive Bladder - Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI-RS 2025.

Phenotyping Overactive Bladder - Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI-RS 2025.

Journal: Neurourology and urodynamics

Published: October 06, 2025

How Can We Make Progress in the Management of Bladder Pain Syndrome? ICI-RS 2025.

How Can We Make Progress in the Management of Bladder Pain Syndrome? ICI-RS 2025.

Journal: Neurourology and urodynamics

Published: September 07, 2025

Interstitial Cystitis/Bladder Pain Syndrome in Men.

Interstitial Cystitis/Bladder Pain Syndrome in Men.

Journal: Neurourology and urodynamics

Published: May 19, 2025

Do We Have Sufficient Evidence to Derive Innovative Approaches to Assessing Unmet Need, Delivering Education on Bladder and Bowel Continence Health, and Providing a Better Environment for Joint Decision-Making? ICI-RS 2024.

Do We Have Sufficient Evidence to Derive Innovative Approaches to Assessing Unmet Need, Delivering Education on Bladder and Bowel Continence Health, and Providing a Better Environment for Joint Decision-Making? ICI-RS 2024.

Journal: Neurourology and urodynamics

Published: November 28, 2024

Urethral bulking agents and pelvic floor muscle training for the treatment of stress urinary incontinence in female patients with multiple sclerosis.

Urethral bulking agents and pelvic floor muscle training for the treatment of stress urinary incontinence in female patients with multiple sclerosis.

Journal: Bladder (San Francisco, Calif.)

Published: October 29, 2024

Does Surgical Treatment for Benign Prostate Enlargement (BPE)-Related Bladder Outlet Obstruction (BOO) Benefit Patients with Central Nervous System Diseases? A Systematic Review.

Does Surgical Treatment for Benign Prostate Enlargement (BPE)-Related Bladder Outlet Obstruction (BOO) Benefit Patients with Central Nervous System Diseases? A Systematic Review.

Journal: Journal of clinical medicine

Published: August 30, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026